同种异体造血移植的临床试验
总计2678个结果
-
St. Jude Children's Research HospitalAssisi Foundation; The Hartwell Foundation完全的
-
Nanfang Hospital of Southern Medical UniversityPeking University People's Hospital; Sun Yat-sen University; Guangzhou First People's Hospital; Sun... 和其他合作者未知
-
Arizona State UniversityNational Cancer Institute (NCI); Mayo Clinic完全的
-
UNC Lineberger Comprehensive Cancer Center完全的
-
Nanfang Hospital of Southern Medical UniversityPeking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen Memorial Hospital... 和其他合作者未知同种异体造血干细胞移植 | 最小残留病 | 费城染色体阳性急性淋巴细胞白血病 | 酪氨酸激酶抑制剂中国
-
China Medical University Hospital未知Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease
-
Sheng-Li Xue, MDNorthern Jiangsu Province People's Hospital; The Second People's Hospital of Huai'an; First Affiliated... 和其他合作者招聘中
-
Abramson Cancer Center of the University of Pennsylvania完全的造血干细胞移植 | 移植物抗宿主病
-
Shanghai Jiao Tong University School of Medicine完全的
-
Fundación Pública Andaluza para la gestión de la...Grupo Espanol de trasplantes hematopoyeticos y terapia celular; Instituto de Salud Carlos III完全的
-
St. Jude Children's Research Hospital完全的
-
Nanfang Hospital of Southern Medical UniversityXiangya Hospital of Central South University; Peking University People's Hospital; The First Affiliated... 和其他合作者完全的
-
Hospital Authority, Hong KongNovartis Pharmaceuticals; The Hong Kong Blood Cancer Foundation未知
-
National Cancer Institute (NCI)暂停
-
Ankara UniversityThe Scientific and Technological Research Council of Turkey完全的
-
Institut Paoli-Calmettes完全的实体瘤 | 血液系统恶性肿瘤 | 同种异体移植 | 同种异体细胞移植法国
-
Stanford UniversityOrca Biosystems, Inc.招聘中骨髓增生异常综合征 | 骨髓增生性疾病 | 急性白血病 | 慢性粒细胞白血病 | 同种异体造血细胞移植 (HCT) | 晚期血液系统恶性肿瘤美国
-
Nanfang Hospital of Southern Medical UniversityPeking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen Memorial Hospital... 和其他合作者完全的
-
University Hospital, Limoges招聘中
-
Oncoimmune, Inc., a subsidiary of Merck & Co.,...National Cancer Institute (NCI); University of Michigan Rogel Cancer Center; Ohio State University 和其他合作者完全的Efprezimod Alfa (CD24Fc, MK-7110) 用于预防清髓性同种异体造血干细胞移植 (HSCT) 后急性移植物抗宿主病 (GVHD) 的 II 期试验 (MK-7110-002)白血病 | 造血干细胞移植 | 移植物抗宿主病美国
-
Assistance Publique - Hôpitaux de Paris完全的
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)撤销
-
Nanfang Hospital of Southern Medical UniversityPeking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen Memorial Hospital... 和其他合作者完全的
-
Instituto de Investigación Sanitaria de la Fundación...完全的
-
PETHEMA Foundation完全的
-
First Affiliated Hospital Xi'an Jiaotong University尚未招聘
-
Nanfang Hospital of Southern Medical UniversityXiangya Hospital of Central South University; Peking University People's Hospital; Second Affiliated... 和其他合作者招聘中
-
Assistance Publique - Hôpitaux de Paris尚未招聘败血症 | 感染性休克 | 血液系统恶性肿瘤 | 瘤 | 同种异体干细胞移植
-
Massachusetts General HospitalWashington University School of Medicine; Medical College of Wisconsin; Vanderbilt University; Ohio...招聘中
-
Institute of Hematology & Blood Diseases Hospital...招聘中
-
Nanfang Hospital of Southern Medical University未知